ArticleJACC. CardioOncology2023

Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients.

Stephanie Carlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.